4
Changes in Ownership
Foghorn Therapeutics Inc. Filed Acc 0001562180-25-000501
Options or other derivatives
- Chief Executive Officer acquired 400,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| GOTTSCHALK ADRIAN Chief Executive Officer | 2025-01-22 | Grant or award · Stock Option (right to buy) | +400,000 | $4.37 | $1,748,000 | 400,000 | D |
Loading xslF345X05/primarydocument.xml…